AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33177324 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen administration influenced by parental coping styles
Number of subjects: 173
Study 616841895 — intervention group
Group type: EXPERIMENTAL
Intervention: LEEP
Number of subjects: 149
Study 616841895 — intervention group
Group type: COMPARATOR
Intervention: CKC
Number of subjects: 149
Study 35264345 — intervention group
Group type: EXPERIMENTAL
Intervention: Workplace intervention including 2-3 workshops, 2-3 consultative meetings with supervisors, follow-up meeting for the work unit, online meetings with supervisors.
Number of subjects: 450
Study 35264345 — intervention group
Group type: COMPARATOR
Intervention: Control group (age-matched, sex-matched, occupation-matched) receiving no intervention.
Number of subjects: 450
Study 32830383 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin hygiene education and skills-training behavioral intervention (SKIN)
Number of subjects: 252
Study 32830383 — intervention group
Group type: COMPARATOR
Intervention: Usual care (informational brochure about substance use treatment options and needle exchange programs)
Number of subjects: 252
Study 32799422 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care nerve conduction device (DPNCheck™)
Number of subjects: 375
Study 32799422 — intervention group
Group type: COMPARATOR
Intervention: Nerve conduction study using a conventional electromyography system
Number of subjects: 375
Study 36102565 — intervention group
Group type: EXPERIMENTAL
Intervention: Alvimopan
Number of subjects: 62
Study 36102565 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 34001889 — intervention group
Group type: COMPARATOR
Intervention: Arm 1: Not contacted
Number of subjects: 80759
Study 34001889 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm 2: Follows current guidelines
Number of subjects: 80759
Study 34001889 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm 3: Follows a more intensive strategy
Number of subjects: 80759
Study 33151928 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct attitude
Number of subjects: 422
Study 33151928 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct subjective norm
Number of subjects: 422
Study 33151928 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct perceived behavioral control
Number of subjects: 422
Study 33151928 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect attitude
Number of subjects: 422
Study 33151928 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect perceived behavioral control
Number of subjects: 422
Study 35769034 — intervention group
Group type: COMPARATOR
Intervention: Gepotidacin 100-3000 mg (single ascending doses)
Number of subjects: 0
Study 35769034 — intervention group
Group type: COMPARATOR
Intervention: Gepotidacin 400 mg twice daily to 2000 mg thrice daily (repeat ascending doses)
Number of subjects: 0
Study 35769034 — intervention group
Group type: COMPARATOR
Intervention: Gepotidacin 1500 mg twice daily (repeat doses in elderly)
Number of subjects: 0
Study 35769034 — intervention group
Group type: COMPARATOR
Intervention: Gepotidacin with a moderate-fat meal
Number of subjects: 0
Study 33089472 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing the Black patient
Number of subjects: 83
Study 33089472 — intervention group
Group type: COMPARATOR
Intervention: Viewing the White patient
Number of subjects: 83
Study 32505171 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose glucose infusion (0.1 g/kg/hr. for 1 h followed by 0.05 g/kg/hr. for 1 h; LG group)
Number of subjects: 31
Study 32505171 — intervention group
Group type: COMPARATOR
Intervention: No glucose infusion (0G group)
Number of subjects: 31
Study 35896864 — intervention group
Group type: EXPERIMENTAL
Intervention: Less invasive surfactant administration (LISA)
Number of subjects: 211
Study 35896864 — intervention group
Group type: COMPARATOR
Intervention: Conventional endotracheal intubation (Control)
Number of subjects: 211
Study 34505889 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular expectation briefing
Number of subjects: 152
Study 34505889 — intervention group
Group type: EXPERIMENTAL
Intervention: High expectation briefing
Number of subjects: 152
Study 34505889 — intervention group
Group type: COMPARATOR
Intervention: Regular adverse side effect briefing
Number of subjects: 152
Study 34505889 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense adverse side effect briefing
Number of subjects: 152
Study 32115970 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (100 mg twice a day for seven days)
Number of subjects: 40
Study 32115970 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10
Number of subjects: 40
Study 32115970 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard treatment of sepsis)
Number of subjects: 40
Study 35351936 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo induced expectation with oxytocin nasal spray
Number of subjects: 0
Study 35351936 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo induced expectation
Number of subjects: 0
Study 33730455 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegcetacoplan
Number of subjects: 80
Study 33730455 — intervention group
Group type: COMPARATOR
Intervention: Eculizumab
Number of subjects: 80
Study 35545155 — intervention group
Group type: EXPERIMENTAL
Intervention: INCREM intervention
Number of subjects: 52
Study 35545155 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation programme
Number of subjects: 52
Study 35545155 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 52
Study 33513182 — intervention group
Group type: EXPERIMENTAL
Intervention: Late initiation of antenatal care (after 12 weeks of gestation)
Number of subjects: 389
Study 33513182 — intervention group
Group type: EXPERIMENTAL
Intervention: Family size of ≥ 4
Number of subjects: 389
Study 33513182 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal age ≥ 25 years
Number of subjects: 389
Study 33513182 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived the right time of booking > 12 weeks of gestation
Number of subjects: 389
Study 33513182 — intervention group
Group type: EXPERIMENTAL
Intervention: Not being a member of women's health developmental army
Number of subjects: 389
Study 33513182 — intervention group
Group type: EXPERIMENTAL
Intervention: ANC not attended previously
Number of subjects: 389
Study 32163677 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel therapies (NT)
Number of subjects: 0
Study 32163677 — intervention group
Group type: COMPARATOR
Intervention: Early radical cystectomy (ERC)
Number of subjects: 0
Study 35033564 — intervention group
Group type: EXPERIMENTAL
Intervention: Education on Essential Newborn Care (ENC) through pictorial aids, demonstrations, and practice sessions
Number of subjects: 88
Study 35033564 — intervention group
Group type: COMPARATOR
Intervention: Ongoing public health programs (control group)
Number of subjects: 88
Study 33384385 — intervention group
Group type: EXPERIMENTAL
Intervention: SAFE intervention (five-session family therapy-based intervention delivered over 16 weeks)
Number of subjects: 34
Study 33384385 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 34
Study 35079895 — intervention group
Group type: EXPERIMENTAL
Intervention: Raw corn starch
Number of subjects: 20
Study 35079895 — intervention group
Group type: EXPERIMENTAL
Intervention: Isomaltooligosaccharide (IMO)
Number of subjects: 20
Study 35079895 — intervention group
Group type: EXPERIMENTAL
Intervention: IMO/sucromalt combination
Number of subjects: 20
Study 35079895 — intervention group
Group type: COMPARATOR
Intervention: Rapidly digestible carbohydrate control (maltodextrin)
Number of subjects: 20
Study 35079895 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall SDCs
Number of subjects: 20
Study 35766659 — intervention group
Group type: EXPERIMENTAL
Intervention: Capillary refill time-targeted resuscitation based on clinical and hemodynamic phenotypes.
Number of subjects: 1500
Study 35766659 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group).
Number of subjects: 1500
Study 32459669 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time visual feedback during overground walking training
Number of subjects: 24
Study 32459669 — intervention group
Group type: COMPARATOR
Intervention: Control group (no real-time visual feedback)
Number of subjects: 24
Study 35863697 — intervention group
Group type: EXPERIMENTAL
Intervention: Summit program
Number of subjects: 64
Study 35863697 — intervention group
Group type: COMPARATOR
Intervention: Pain tracking app (Control)
Number of subjects: 64
Study 33512778 — intervention group
Group type: EXPERIMENTAL
Intervention: Total thyroidectomy + central lymph node dissection
Number of subjects: 2108
Study 33512778 — intervention group
Group type: COMPARATOR
Intervention: Neck lateral lymph node dissection
Number of subjects: 2108
Study 32804979 — intervention group
Group type: EXPERIMENTAL
Intervention: Early mobilization (EM)
Number of subjects: 59
Study 32804979 — intervention group
Group type: COMPARATOR
Intervention: Control (standard care)
Number of subjects: 59
Study 32804979 — intervention group
Group type: COMPARATOR
Intervention: Control (current guidelines)
Number of subjects: 59
Study 32804979 — intervention group
Group type: COMPARATOR
Intervention: Control (evidence gap)
Number of subjects: 59
Study 35732749 — intervention group
Group type: EXPERIMENTAL
Intervention: Mucosamin® oral spray
Number of subjects: 60
Study 35732749 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 34072630 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg of elemental iron as ferrous sulfate
Number of subjects: 376
Study 34072630 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 376
Study 34877531 — intervention group
Group type: EXPERIMENTAL
Intervention: Myomectomy
Number of subjects: 254
Study 34877531 — intervention group
Group type: COMPARATOR
Intervention: Uterine artery embolization (UAE)
Number of subjects: 254
Study 35929569 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaphragm pacemaker and pulmonary rehabilitation therapies along with basic ICU nursing and conventional rehabilitation treatment
Number of subjects: 40
Study 35929569 — intervention group
Group type: COMPARATOR
Intervention: Basic ICU nursing and conventional rehabilitation treatment
Number of subjects: 40
Study 35929569 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaphragm pacemaker and pulmonary rehabilitation therapies
Number of subjects: 40
Study 33527332 — intervention group
Group type: EXPERIMENTAL
Intervention: Discontinuing PPIs (Group A)
Number of subjects: 351
Study 33527332 — intervention group
Group type: EXPERIMENTAL
Intervention: Replacement with H2 blockers (Group B)
Number of subjects: 351
Study 33527332 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuing PPIs (Group C)
Number of subjects: 351
Study 33527332 — intervention group
Group type: EXPERIMENTAL
Intervention: H2 blockers (Group D)
Number of subjects: 351
Study 33527332 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group E)
Number of subjects: 351
Study 34511458 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated use of climatic‐, balneo‐ and focused magnetic therapy with anti‐tuberculosis chemotherapy
Number of subjects: 120
Study 34511458 — intervention group
Group type: EXPERIMENTAL
Intervention: Drinking mineral water 'Teberda' in addition to anti‐tuberculosis chemotherapy
Number of subjects: 120
Study 34511458 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused magnetic therapy in addition to drinking mineral water 'Teberda' and anti‐tuberculosis chemotherapy
Number of subjects: 120
Study 34511458 — intervention group
Group type: COMPARATOR
Intervention: Climatic‐ and anti‐tuberculosis chemotherapy (comparison group)
Number of subjects: 120
Study 32532698 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonpreferred music first, then preferred music
Number of subjects: 31
Study 32532698 — intervention group
Group type: COMPARATOR
Intervention: Preferred music first, nonpreferred music second
Number of subjects: 31
Study 32532698 — intervention group
Group type: COMPARATOR
Intervention: Overall comparison of preferred music vs nonpreferred music
Number of subjects: 31
Study 33978284 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with MID
Number of subjects: 222
Study 33978284 — intervention group
Group type: COMPARATOR
Intervention: Family members
Number of subjects: 222
Study 35131017 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic DPC
Number of subjects: 62
Study 35131017 — intervention group
Group type: COMPARATOR
Intervention: Non-prophylactic DPC
Number of subjects: 62
Study 33737410 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-amoxiclav 400/57 twice daily for 5 days
Number of subjects: 271
Study 33737410 — intervention group
Group type: COMPARATOR
Intervention: Placebo twice daily for 5 days
Number of subjects: 271
Study 33737410 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-amoxiclav 400/57
Number of subjects: 271
Study 33737410 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 271
Study 35687858 — intervention group
Group type: EXPERIMENTAL
Intervention: HP-3070 7.6 mg/24 h
Number of subjects: 442
Study 35687858 — intervention group
Group type: EXPERIMENTAL
Intervention: HP-3070 3.8 mg/24 h
Number of subjects: 442
Study 35687858 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 442
Study 33145981 — intervention group
Group type: EXPERIMENTAL
Intervention: Out-of-pocket expenditure (OOPE) on direct medical and nonmedical goods and services
Number of subjects: 130
Study 33145981 — intervention group
Group type: EXPERIMENTAL
Intervention: Out-of-pocket expenditure on direct medical costs
Number of subjects: 130
Study 33145981 — intervention group
Group type: EXPERIMENTAL
Intervention: Out-of-pocket expenditure on direct nonmedical costs
Number of subjects: 130
Study 33145981 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct medical expenditure
Number of subjects: 130
Study 33145981 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictors of direct medical expenditure
Number of subjects: 130
Study 33145981 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictors of direct nonmedical expenditure
Number of subjects: 130
Study 35579077 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle mass phenotype grading system based on MUAMA and HGS
Number of subjects: 1660
Study 35579077 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 3 (worst muscle mass phenotype)
Number of subjects: 1660
Study 35579077 — intervention group
Group type: EXPERIMENTAL
Intervention: MUAMA and HGS values
Number of subjects: 1660
Study 32393279 — intervention group
Group type: EXPERIMENTAL
Intervention: Televisits via videoconference
Number of subjects: 202
Study 32393279 — intervention group
Group type: COMPARATOR
Intervention: Standard in-person outpatient follow-up visits (control arm)
Number of subjects: 202
Study 35171210 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump CABG
Number of subjects: 2203
Study 35171210 — intervention group
Group type: COMPARATOR
Intervention: On-pump CABG
Number of subjects: 2203
Study 33890268 — intervention group
Group type: EXPERIMENTAL
Intervention: Aural Rehabilitation (AR) intervention consisting of auditory training and psychosocial counseling
Number of subjects: 25
Study 33890268 — intervention group
Group type: COMPARATOR
Intervention: Active control group engaged in cognitive stimulation activities
Number of subjects: 25
Study 32562206 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran dual therapy (110 or 150 mg twice daily, with clopidogrel or ticagrelor)
Number of subjects: 2678
Study 32562206 — intervention group
Group type: COMPARATOR
Intervention: Warfarin triple therapy (with clopidogrel or ticagrelor, and aspirin for 1-3 months)
Number of subjects: 2678
Study 32562206 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran dual therapy (110 or 150 mg)
Number of subjects: 2678
Study 32562206 — intervention group
Group type: COMPARATOR
Intervention: Warfarin triple therapy
Number of subjects: 2678
Study 34229263 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium breve BR03 (DSM 16604) and B. breve B632 (DSM 24706) at 2 × 10^9 CFU/AFU/day for 8 weeks
Number of subjects: 101
Study 34229263 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 101
Study 35300665 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention (8 yoga sessions synced with anatomy topics)
Number of subjects: 64
Study 35300665 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group (normal anatomy curriculum, option to participate in yoga after course)
Number of subjects: 64
Study 33754941 — intervention group
Group type: EXPERIMENTAL
Intervention: Microwave ablation (MWA)
Number of subjects: 552
Study 32199339 — intervention group
Group type: COMPARATOR
Intervention: multisession transcranial direct current stimulation (tDCS)
Number of subjects: 101
Study 35901367 — intervention group
Group type: EXPERIMENTAL
Intervention: Engagement-focused parent-teen treatment (STAND)
Number of subjects: 854
Study 35901367 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based usual care
Number of subjects: 854
Study 35901367 — intervention group
Group type: EXPERIMENTAL
Intervention: Summer Treatment Program-Adolescent (STP-A)
Number of subjects: 854
Study 35901367 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard behavioral parent training + organization skills training (BPT/OST)
Number of subjects: 854
Study 35901367 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 854
Study 35901367 — intervention group
Group type: EXPERIMENTAL
Intervention: BPT/OST and STP-A
Number of subjects: 854
Study 35901367 — intervention group
Group type: EXPERIMENTAL
Intervention: STAND, BPT/OST, and STP-A
Number of subjects: 854
Study 35901367 — intervention group
Group type: COMPARATOR
Intervention: Parent contingency management and disruptive classroom behavior
Number of subjects: 854
Study 33412896 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive Self‐Management (CSM) intervention including dietary education and cognitive behavioral therapy
Number of subjects: 30
Study 33412896 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 30
Study 35162195 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional Support System (NSS)
Number of subjects: 80
Study 32864754 — intervention group
Group type: COMPARATOR
Intervention: Tetramethylpyrazine nitrone (TBN) 50-1800 mg IV infusion over 30 min (SAD study)
Number of subjects: 92
Study 32864754 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetramethylpyrazine nitrone (TBN) 700 or 1400 mg twice daily for 6.5 days (MAD study)
Number of subjects: 92
Study 33380585 — intervention group
Group type: EXPERIMENTAL
Intervention: Pectoral nerve block with 10 mL of 2% lignocaine as an initial bolus followed by 10 mL every 8 hours up to 24 hours (Group I)
Number of subjects: 20
Study 33380585 — intervention group
Group type: COMPARATOR
Intervention: No regional block (Group II)
Number of subjects: 20
Study 33380585 — intervention group
Group type: EXPERIMENTAL
Intervention: Pectoral nerve block (Group I)
Number of subjects: 20
Study 35579420 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-D models of echocardiographic imaging planes
Number of subjects: 39
Study 35579420 — intervention group
Group type: COMPARATOR
Intervention: Self-explanatory text about echocardiographic imaging planes (control group)
Number of subjects: 39
Study 34059372 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccines For Babies (VFB) intervention
Number of subjects: 250
Study 34059372 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 250
Study 32848377 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 28
Study 32848377 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Training (Control)
Number of subjects: 28
Study 34716885 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminiscence therapy involved care (RTIC)
Number of subjects: 152
Study 34716885 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 152
Study 33323886 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological intervention administered by a psychiatrist before surgery and ongoing thereafter
Number of subjects: 49
Study 33323886 — intervention group
Group type: COMPARATOR
Intervention: Routine TKA care without psychological interventions
Number of subjects: 49
Study 33323886 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological intervention
Number of subjects: 49
Study 35748086 — intervention group
Group type: EXPERIMENTAL
Intervention: Leaflet resection
Number of subjects: 104
Study 35748086 — intervention group
Group type: COMPARATOR
Intervention: Leaflet preservation
Number of subjects: 104
Study 35748086 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 104
Study 34264305 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib 400 mg once daily for 2 years
Number of subjects: 2639
Study 34264305 — intervention group
Group type: COMPARATOR
Intervention: Placebo once daily for 2 years
Number of subjects: 2639
Study 36180067 — intervention group
Group type: EXPERIMENTAL
Intervention: ActivOnline (AO)
Number of subjects: 107
Study 36180067 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 107
Study 34452956 — intervention group
Group type: EXPERIMENTAL
Intervention: Eltrombopag
Number of subjects: 162
Study 34452956 — intervention group
Group type: COMPARATOR
Intervention: Standard first-line management
Number of subjects: 162
Study 33302648 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyethylene glycol 4000, 10 g, twice daily
Number of subjects: 113
Study 33302648 — intervention group
Group type: COMPARATOR
Intervention: Lactulose, 15 mL, twice daily
Number of subjects: 113
Study 34986170 — intervention group
Group type: EXPERIMENTAL
Intervention: Zvandiri peer counselling with problem-solving therapy (PST)
Number of subjects: 842
Study 34986170 — intervention group
Group type: COMPARATOR
Intervention: Standard Zvandiri care (control)
Number of subjects: 842
Study 33044356 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone 50 mg daily for 5 days
Number of subjects: 52
Study 33044356 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 33294980 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg
Number of subjects: 85
Study 33294980 — intervention group
Group type: COMPARATOR
Intervention: Rosuvastatin 20 mg
Number of subjects: 85
Study 33294980 — intervention group
Group type: EXPERIMENTAL
Intervention: Both atorvastatin and rosuvastatin
Number of subjects: 85
Study 32911474 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride Varnish (FV)
Number of subjects: 1284